Amicus Therapeutics Inc. buy Morgan Stanley
Start price
10.05.24
/
50%
€8.60
Target price
10.05.25
€17.64
Performance (%)
-37.79%
End price
11.05.25
€5.35
Summary
This prediction ended on 11.05.25 with a price of €5.35. Massive losses of -37.79% were the result for the BUY prediction by Morgan_Stanley. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 0.820% | 0.820% | 52.795% |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Morgan Stanley from $20.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.45
11.10.24
11.10.24
€16.44
11.10.25
11.10.25
-24.34%
12.10.25
12.10.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
19.12.23
19.12.23
€18.24
19.12.24
19.12.24
-22.50%
20.12.24
20.12.24